1. <dfn id="8ngdu"></dfn>

      1. <dfn id="8ngdu"></dfn>
        <rp id="8ngdu"><address id="8ngdu"></address></rp>
          <video id="8ngdu"><menu id="8ngdu"><kbd id="8ngdu"></kbd></menu></video>

          1. <b id="8ngdu"></b>

          Personal and Home Care Products
          CIRS Group
          Chemicals
          Cosmetic
          Food
          Medical Devices
          Agrochemicals
          CIRS Testing
          Carbon Neutrality
          Search
          Mocra
          On November 26, 2024, the US Food and Drug Administration (FDA) proposed establishing and requiring standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). This proposed rule, if finalized, would protect consumers by – to the extent it reduces exposure to asbestos – resulting in fewer asbestos-related illnesses.
          On December 11, 2024, the US Food and Drug Administration (FDA) issued updated guidance for industry on the registration and listing of cosmetic product facilities and products. The guidance finalizes the frequently asked questions and answers (FAQ) in Appendix B (Q1-19). In addition, three new FAQs (Q20-22) in Appendix B of the guidance are marked as “for comment purposes only”. These three FAQs are available for comments until January 13, 2025.
          The US Food and Drug Administration has published a Structured Product Labeling (SPL) Implementation Guide with Validation Procedures. Cosmetic product facility registrations and product listings are now included within the SPL framework. The Implementation Guide can be used to develop SPL authoring tools. In the future, once FDA begins accepting data, users may transmit SPL-formatted submissions through FDA’s Electronic Submissions Gateway (ESG), or SPL authoring software including Xforms, for cosmetic product facility registrations and product listings, mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
          On August 7, 2023, the US Food and Drug Administration (FDA) published draft guidance on cosmetic product facility registrations and product listings, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). When finalized, the draft guidance will assist stakeholders with cosmetic product facility registration and product listing submissions to FDA, by describing who is responsible for making the registration and listing submissions, what information to include, how to submit, and when to submit, as well as certain exemptions to the registration and listing requirements.
          1. <dfn id="8ngdu"></dfn>

            1. <dfn id="8ngdu"></dfn>
              <rp id="8ngdu"><address id="8ngdu"></address></rp>
                <video id="8ngdu"><menu id="8ngdu"><kbd id="8ngdu"></kbd></menu></video>

                1. <b id="8ngdu"></b>

                亚洲国产精品激情在线观看